CNS & Neurological Disorders - Drug Targets
Title:Message from Editor-in-Chief
Volume: 13 Issue: 1
Author(s): Stephen D. Skaper
Affiliation:
Export Options
About this article
Cite this article as:
Skaper D. Stephen, Message from Editor-in-Chief, CNS & Neurological Disorders - Drug Targets 2014; 13 (1) . https://dx.doi.org/10.2174/187152731301140210113429
DOI https://dx.doi.org/10.2174/187152731301140210113429 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
27
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Serotonin Type-4 (5-HT4) Receptors as Therapeutic Targets: 5-HT4 Receptor Antagonists
Current Medicinal Chemistry - Central Nervous System Agents Evidence of Lifestyle Modification in the Management of Hypercholesterolemia
Current Cardiology Reviews Clinical Development of MET Targeted Therapy For Human Cancer
Current Cancer Therapy Reviews Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
Current Drug Metabolism Medical Treatment of Aortic Aneurysms in Marfan Syndrome and other Heritable Conditions
Current Cardiology Reviews Liquid Chromatographic, Spectrophotometric and Potentiometric pK<sub>a</sub> Determination of Ranitidine and Famotidine
Current Drug Therapy Recent Developments in Cholinesterases Inhibitors for Alzheimers Disease Treatment
Current Medicinal Chemistry A Clinical Perspective: Anti Taus Treatment in Alzheimers Disease
Current Alzheimer Research Syntheses and Evaluation of Asymmetric Curcumin Analogues as Potential Multifunctional Agents for the Treatment of Alzheimer’s Disease
Current Alzheimer Research Novelty in Inflammation and Immunomodulation in Migraine
Current Pharmaceutical Design The Role of Bacteria and Viruses in Chronic Obstructive Pulmonary Disease
Current Respiratory Medicine Reviews Ischemic Tolerance Induced by Normobaric Hyperoxia and Evaluation of Group I and II Metabotropic Glutamate Receptors
Current Neurovascular Research Synthesis and Application of Stable Nitroxide Free Radicals Fused with Carbocycles and Heterocycles
Current Organic Chemistry Inducible Nitric Oxide Synthase as a Possible Target in Hypertension
Current Drug Targets LW-AFC, A New Formula Derived from Liuwei Dihuang Decoction, Ameliorates Cognitive Deterioration and Modulates Neuroendocrine-Immune System in SAMP8 Mouse
Current Alzheimer Research Image Based Brain Segmentation: From Multi-Atlas Fusion to Deep Learning
Current Medical Imaging Serotonin-Norepinephrine Reuptake Inhibitors for Pain Control: Premise and Promise
Current Neuropharmacology Intrathecal Enzyme Replacement Therapy for Mucopolysaccharidosis I: Translating Success in Animal Models to Patients
Current Pharmaceutical Biotechnology Genetic Association Analysis of NOS1 and Methamphetamine-Induced Psychosis Among Japanese
Current Neuropharmacology Diagnostic and Therapeutic Potentials of microRNAs in Heart Failure
Current Topics in Medicinal Chemistry